Sofetabart Mipitecan
N/A
Report date: 2026/04/20 20:01:59
Base Information
Drug NameSofetabart Mipitecan
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[26]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEli Lilly And CompanyLoxo Oncology Inc
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A